Idexx Laboratories Recurring revenue — Total Revenue increased by 4.2% to $73.54M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $65.79M to $73.54M. Over 4 years (FY 2021 to FY 2025), Recurring revenue — Total Revenue shows an upward trend with a 17.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates higher customer loyalty and a more stable, predictable revenue base, while a decrease may suggest reliance on cyclical capital equipment sales.
This metric represents the portion of total revenue generated from recurring sources, such as diagnostic test kits, refe...
High-quality healthcare and diagnostic companies typically target high recurring revenue ratios to minimize volatility and improve long-term valuation multiples.
idxx_segment_recurring_revenue_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.87M | $36.87M | $36.87M | $45.24M | $45.24M | $45.24M | $45.24M | $51.71M | $53.73M | $54.61M | $54.56M | $59.70M | $63.12M | $64.64M | $62.90M | $65.79M | $68.95M | $70.99M | $70.60M | $73.54M |
| QoQ Change | — | +0.0% | +0.0% | +22.7% | +0.0% | +0.0% | +0.0% | +14.3% | +3.9% | +1.6% | -0.1% | +9.4% | +5.7% | +2.4% | -2.7% | +4.6% | +4.8% | +2.9% | -0.5% | +4.2% |
| YoY Change | — | — | — | — | +22.7% | +22.7% | +22.7% | +14.3% | +18.7% | +20.7% | +20.6% | +15.5% | +17.5% | +18.4% | +15.3% | +10.2% | +9.2% | +9.8% | +12.2% | +11.8% |